3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Recurrence
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Gemcitabine
100
130-nm albumin-bound paclitaxel
34
Oxaliplatin
28
Capecitabine
27
Fluorouracil
25
Albumin-Bound Paclitaxel
23
Leucovorin
19
Irinotecan
18
Erlotinib Hydrochloride
14
Cyclophosphamide
12
Radiosurgery
11
pembrolizumab
10
Radiotherapy
10
Nivolumab
10
Bevacizumab
10
Surgical Procedures, Operative
9
avelumab
7
Docetaxel
7
Taxes
6
Cisplatin
6
ruxolitinib
5
folfirinox
5
Specimen Handling
5
Paclitaxel
5
Everolimus
5
Cetuximab
5
ALT-803
5
trametinib
4
spartalizumab
4
fludarabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pancreatic Neoplasms
×
epitumomab
×
Clear all
NCT02132403
2015-05-01
PM-01
University of Illinois at Chicago
Phase 1
Terminated
3 enrolled